3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
68
Carcinoma, Non-Small-Cell Lung
40
Carcinoma, Renal Cell
36
Neoplasm Metastasis
22
Carcinoma, Hepatocellular
15
Neoplasms
13
Colorectal Neoplasms
13
Brain Neoplasms
13
Skin Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Pancreatic Neoplasms
10
Lung Neoplasms
10
Kidney Neoplasms
10
Uveal Melanoma
9
Ovarian Neoplasms
9
Urinary Bladder Neoplasms
8
Sarcoma
8
Prostatic Neoplasms
8
Carcinoma, Transitional Cell
8
Mesothelioma
7
Glioblastoma
7
Clear-cell metastatic renal cell carcinoma
7
Carcinoma, Merkel Cell
7
Recurrence
6
Colonic Neoplasms
6
Triple Negative Breast Neoplasms
5
Small Cell Lung Carcinoma
5
Mesothelioma, Malignant
5
Carcinoma
5
Stomach Neoplasms
4
Interventions
Cisplatin
5
pembrolizumab
4
Surveys and Questionnaires
2
Radiotherapy
2
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
2
Fluorouracil
2
Docetaxel
2
Cetuximab
2
niraparib
1
monalizumab
1
durvalumab
1
dostarlimab
1
Tablets
1
Surgical Flaps
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
LY2940680
1
Interviews as Topic
1
Combined Modality Therapy
1
Chemical Fractionation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Diseases
×
Ipilimumab
×
1 year
×
Clear all
No trials found.